A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies

Abstract

BACKGROUND Stromal derived factor-1α (SDF-1α/CXCL12) is a chemokine that is up-regulated in diseases characterised by tissue hypoxia, including myocardial infarction, ischaemic cardiomyopathy and remote ischaemic conditioning (RIC), a technique of cyclical, non-injurious ischaemia applied remote from the heart that protects the heat from lethal ischaemia… (More)
DOI: 10.1371/journal.pone.0174447

Topics

10 Figures and Tables

Cite this paper

@inproceedings{Bromage2017ANR, title={A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies}, author={Daniel Ian Bromage and Stasa Taferner and Mahesh Krishna Pillai and Derek M Yellon and Sean M Davidson}, booktitle={PloS one}, year={2017} }